A Clinical Study of Adenosine on Percutaneous Transluminal Coronary Angioplasty
Xiaojun Tan
Abstract
Xiaojun Tan
Abstract
Objective To investigate if adenosine can improve the myocardial protection after percutaneous transluminal coronary angioplasty.Methods 171 patients with CHD were divided into two groups(adenosine A group and control B group)at random,Cardiac troponin I(cTnI) were measured in two groups before PCI,6、12、24、48、72 hours after PCI.Results No significant difference was shown between two groups in cTnI before PCI.The percentage of cTnI rising above the cutoff was 11% in group A and 24% in group B.Group A was superiors to group B(P0.01) after PCI.Conclusion Adenosine can reduce myocardial injury in PCI.It can be regarded as a reliable method in PCI.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate if adenosine can improve the myocardial protection after percutaneous transluminal coronary angioplasty.Methods 171 patients with CHD were divided into two groups(adenosine A group and control B group)at random,Cardiac troponin I(cTnI) were measured in two groups before PCI,6、12、24、48、72 hours after PCI.Results No significant difference was shown between two groups in cTnI before PCI.The percentage of cTnI rising above the cutoff was 11% in group A and 24% in group B.Group A was superiors to group B(P0.01) after PCI.Conclusion Adenosine can reduce myocardial injury in PCI.It can be regarded as a reliable method in PCI.
Key concepts: Conventional PCI, Troponin I, Percutaneous transluminal coronary angioplasty, Percutaneous coronary intervention, Cardiology, Medicine, Internal medicine, Angioplasty